Two polymorphisms in TGFβ1, −509, and +869, which elevate plasma levels of TGFβ1, increase the severity of cystic fibrosis [153] and familial pulmonary hypertension [154]. This evidence concerns the gene TGFB1 and cystic fibrosis.